China Market Growth Spurs Siemens Healthineers To Restructure Asia Ops
Germany-headquartered Siemens Healthineers has uncoupled China from the rest of its Asia business to maximize opportunities in the world’s largest medtech market-in-waiting.
You may also be interested in...
China’s growing market for medtech, estimated at $70bn in 2021, could more than double this decade if the government’s Healthy China 2030 plan stays on track.
China-specific go-to-market strategies are helping global medtechs access the fast-growing medical device market in China, where localization has become the buzzword for foreign players, writes news and analysis portal Omdia.
Governments in the ASEAN bloc continue to build national digital health roadmaps, which Siemens Healthineers’ local head of digitalization Virginia Chan sees as encouraging from many standpoints.